BG62966B1 - Нови полиморфни форми на лезопитрон дихидрохлорида и неговите хидратни форми, методи за тяхното получаване и състави, които ги съдържат - Google Patents

Нови полиморфни форми на лезопитрон дихидрохлорида и неговите хидратни форми, методи за тяхното получаване и състави, които ги съдържат Download PDF

Info

Publication number
BG62966B1
BG62966B1 BG101176A BG10117697A BG62966B1 BG 62966 B1 BG62966 B1 BG 62966B1 BG 101176 A BG101176 A BG 101176A BG 10117697 A BG10117697 A BG 10117697A BG 62966 B1 BG62966 B1 BG 62966B1
Authority
BG
Bulgaria
Prior art keywords
lesopitron dihydrochloride
hydrate
dihydrochloride
lesopitron
called
Prior art date
Application number
BG101176A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101176A (en
Inventor
Roses Pilar Lupon
Navarro Jaime Tomas
Torres Salvador Puig
Constansa Jordi Frigola
Original Assignee
Laboratorios Del Dr.Esteve S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr.Esteve S.A. filed Critical Laboratorios Del Dr.Esteve S.A.
Publication of BG101176A publication Critical patent/BG101176A/xx
Publication of BG62966B1 publication Critical patent/BG62966B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG101176A 1995-05-31 1997-01-27 Нови полиморфни форми на лезопитрон дихидрохлорида и неговите хидратни форми, методи за тяхното получаване и състави, които ги съдържат BG62966B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.
PCT/ES1996/000121 WO1996038439A1 (es) 1995-05-31 1996-05-29 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen

Publications (2)

Publication Number Publication Date
BG101176A BG101176A (en) 1997-08-29
BG62966B1 true BG62966B1 (bg) 2000-12-29

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101176A BG62966B1 (bg) 1995-05-31 1997-01-27 Нови полиморфни форми на лезопитрон дихидрохлорида и неговите хидратни форми, методи за тяхното получаване и състави, които ги съдържат

Country Status (29)

Country Link
US (1) US5872125A (es)
EP (1) EP0771798A1 (es)
JP (1) JPH10503532A (es)
CN (1) CN1076020C (es)
AR (1) AR003952A1 (es)
AU (1) AU699210B2 (es)
BG (1) BG62966B1 (es)
CA (1) CA2196425A1 (es)
CO (1) CO4700461A1 (es)
CZ (1) CZ24797A3 (es)
EE (1) EE9700067A (es)
ES (1) ES2099031B1 (es)
GE (1) GEP20002241B (es)
HU (1) HUP9700284A3 (es)
IL (1) IL118494A0 (es)
IN (1) IN186820B (es)
IS (1) IS4420A (es)
MA (1) MA23883A1 (es)
MX (1) MX9700792A (es)
NO (1) NO310073B1 (es)
NZ (1) NZ308110A (es)
PL (1) PL318280A1 (es)
RU (1) RU2178789C2 (es)
SK (1) SK12697A3 (es)
TR (1) TR199600455A2 (es)
UY (1) UY24241A1 (es)
WO (1) WO1996038439A1 (es)
YU (1) YU32396A (es)
ZA (1) ZA964139B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
CA2196425A1 (en) 1996-12-05
HUP9700284A3 (en) 1998-01-28
MX9700792A (es) 1997-05-31
ZA964139B (en) 1997-02-06
NO970392L (no) 1997-04-01
NZ308110A (en) 1997-08-22
SK12697A3 (en) 1997-07-09
ES2099031A1 (es) 1997-05-01
JPH10503532A (ja) 1998-03-31
ES2099031B1 (es) 1997-12-01
CN1158128A (zh) 1997-08-27
US5872125A (en) 1999-02-16
RU2178789C2 (ru) 2002-01-27
AU699210B2 (en) 1998-11-26
CN1076020C (zh) 2001-12-12
EP0771798A1 (en) 1997-05-07
IL118494A0 (en) 1996-09-12
UY24241A1 (es) 1996-06-14
PL318280A1 (en) 1997-06-09
BG101176A (en) 1997-08-29
IN186820B (es) 2001-11-17
CZ24797A3 (en) 1997-05-14
HU9700284D0 (en) 1997-04-28
AU5765096A (en) 1996-12-18
NO970392D0 (no) 1997-01-29
WO1996038439A1 (es) 1996-12-05
AR003952A1 (es) 1998-09-30
MA23883A1 (fr) 1996-12-31
YU32396A (sh) 1999-07-28
CO4700461A1 (es) 1998-12-29
TR199600455A2 (tr) 1996-12-21
GEP20002241B (en) 2000-09-25
EE9700067A (et) 1997-10-15
IS4420A (is) 1997-01-29
NO310073B1 (no) 2001-05-14
HUP9700284A2 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
DK171694B1 (da) Krystallinsk paroxetinhydrochlorid, farmaceutisk præparat indeholdende dette samt fremstilling deraf
US7504504B2 (en) Methods of preparing aripiprazole crystalline forms
AU752877B2 (en) Novel crystalline forms of an antiviral benzimidazole compound
CZ289216B6 (cs) Trihydrát methansulfonátu 5-(2-(4-(1,2-benzizothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-onu, farmaceutická kompozice a léčivo na jeho bázi
US20220332710A1 (en) Solid forms of a glyt1 inhibitor
KR100409168B1 (ko) 약제의결정변체
US11236073B2 (en) ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof
KR20030042038A (ko) 온단세트론 히드로클로라이드의 신규한 결정 형태 및용매화물 형태와 이들의 제조 방법
BG61489B2 (bg) Хемихидрат на 4-(5,6,7,8-тетрахидроимидазо (1,5-а) пиридин-5-ил/-бензонитрил хидрохлорид
AU753527B2 (en) Form VI 5,6-dichloro-2-(isopropylamino)-1-(beta-L- ribofuranosyl)-1H-benzimidazole
BG62966B1 (bg) Нови полиморфни форми на лезопитрон дихидрохлорида и неговите хидратни форми, методи за тяхното получаване и състави, които ги съдържат
KR20190056398A (ko) 무스카린 아세틸콜린 수용체 작용제의 결정성 다형체
EP2729461B1 (en) Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
EP1813602A1 (en) Crystal of two-ring heterocyclic sulfonamide compound
HUE027309T2 (en) Crystalline solvates of 6- (Piperidin-4-ylix) -2H-isoquinolin-1-one hydrochloride
KR20080106232A (ko) 베시피르딘 클로하이드레이트의 결정형, 그 제조 방법 및 용도
MXPA00009703A (es) Forma vi del 5,6-dicloro-2-(isopropilamino)-1 -(beta-l-ribofuranosil)-1h-bencimidazol
NZ620864B2 (en) Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
MXPA00009734A (es) Nuevas formas cristalinas de un compuesto de bencimidazol antiviral